Bromelain Market

Bromelain Market Size:

The global bromelain market size reached USD 30.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 54.7 Million by 2033, exhibiting a growth rate (CAGR) of 6.2% during 2025-2033. The market is exhibiting stable growth, principally driven by increasing demand in key sectors including cosmetics, pharmaceuticals, and food processing. Moreover, its exceptional skin-soothing, anti-inflammatory, and digestive properties improve its market value. In addition, the escalating demand for natural ingredients among consumers is significantly boosting the market expansion.

Bromelain Market Analysis:

• Major Market Drivers: The market is majorly driven by increasing demand for bromelain in pharmaceuticals, especially for its injury-healing and anti-inflammatory functions. Its utilization in cosmetics, food production, and dietary supplements as a natural enzyme further fosters growth. Moreover, the heightening customer preference for natural products is proliferating its applications across numerous sectors, bolstering the overall demand for bromelain. In addition, its therapeutic advantages in treating digestive and cardiovascular disorders establishes it as a crucial ingredient in modern healthcare system, supporting its sustained growth in this evolving market.
• Key Market Trends: Some key trends that substantially fuel bromelain demand include a rising shift towards clean-label, natural ingredients in food and beverage sector. Its propelling utilization in cosmetics for skin exfoliating and soothing applications also highlight the escalating customer interest in naturally formulated skincare products. In addition, technological advancements in enzyme extraction are improving the profitability of commercial bromelain, facilitating a more cost-efficient and effective production.
• Geographical Trends: North America has emerged has the leading regional market for bromelain, primarily driven by robust demand from the food and pharmaceutical sectors. The increasing adoption of both functional and natural enzymes across these industries is boosting its utilization. Moreover, the region’s growing emphasis on dietary supplements and alternative drugs is further promoting the bromelain market expansion. In addition, North America developed healthcare infrastructure facilitates the product’s utilization in therapeutic applications, especially for digestive health and inflammation treatments, further strengthening its position as the largest regional market for bromelain.
• Competitive Landscape: Some of the major market players in the bromelain industry include Advanced Enzyme Technologies Limited, Bio-gen Extracts Private Limited., Changsha Natureway Co. Ltd., Creative Enzymes, Enzybel International (Floridienne S.A.), Enzyme Development Corporation, Enzyme Technologies (PTY) Ltd., Guangxi Nanning Javely Biological Products Co. Ltd., Hong Mao Biochemicals Co. Ltd., Mitushi Biopharma, Xena Bio Herbals Pvt. Ltd., among many others.
• Challenges and Opportunities: One of the crucial challenges observed in the market is increased cost of enzyme extraction which significantly hinders its extensive application. However, rapid advancements in extraction procedures are offering opportunities for more cost-efficient production. Regulatory policies can also pose as a challenge in certain regions but can be mitigated with proper adherence. Moreover, opportunities are also noted in expanding product applications across emerging economies and sectors, especially in cosmetics and healthcare, where the demand for natural ingredients is constantly soaring, paving the prospects for future market growth.

Bromelain Market Trends:

Increasing Demand in the Pharmaceutical Industry

According to the bromelain market report, the pharmaceutical sector is significantly contributing to the market. The injury-recovery, anti-inflammatory, and anti-coagulant properties of bromelain are substantially fueling its utilization in numerous treatments, such as cardiovascular disorders and arthritis. According to recent industry reports, rheumatoid arthritis (RA) cases are expected to rise by 80% over the next 30 years. As of 2024, approximately 18 million individuals globally are affected by RA, with projections estimating this figure will reach 31.7 million by 2050. Moreover, this trend is further boosted by continuous research into the therapeutic potentials of bromelain, improving its functionality as a natural enzyme in drug development. In addition, the demand for this product as a substitute for synthetic drugs, especially in holistic and natural medicines, is notably supporting the global market expansion.

Rapid Product Adoption in Food and Beverage Sector

The bromelain market overview indicates that the bromelain’s integral role in food processing as a natural enzyme is substantially bolstering its demand within the food and beverage industry. This enzyme is generally leveraged as an additive in dietary supplements and beverages mainly because of its protein-hydrolyzing property, and is also utilized in meat tenderizers. According to a research article published by the National Institutes of Health in March 2023, 60% of the commercial enzymes used in the food industry are proteases, with bromelain among them. Additionally, bromelain is recognized as one of the most widely used plant-based proteases for meat tenderization. In addition, with heightening customer preference for naturally-derived ingredients in food products, bromelain is rapidly emerging as an ideal choice among producers seeking to provide clean-label beverages and food products. Moreover, this trend is anticipated to further fuel market growth due to escalating customer awareness regarding the benefits of enzyme-based foods.

Expanding Product Utilization in the Cosmetics Sector

The cosmetics sector is heavily leveraging bromelain for its skin rejuvenating and exfoliating properties. As customers are increasingly preferring non-irritating as well as natural ingredients in their skincare products, bromelain is gaining notable momentum in cosmetic formulations, aimed at facilitating anti-inflammatory and gentle exfoliation abilities. According to a research article published in the journal Nutrients in June 2024, bromelain can effectively act as an exfoliating agent in cosmetic products. It can gently remove dead skin cells through its proteolytic activity and can enhance skin texture and facilitate skin renewal. Also, it is widely adopted as a gentler, natural alternative to chemical or physical exfoliants. Moreover, bromelain is emerging as an integral ingredient in anti-aging creams, facial masks, and face cleansers. In addition, manufacturers are currently emphasizing on effective, natural, clean formulations to address the evolving demands of consumers, which is ultimately contributing to an optimistic bromelain market outlook.

Bromelain Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on source and application.

Breakup by Source:

• Stem
• Fruit
   

Stem accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the source. This includes stem and fruit. According to the report, stem represented the largest segment.

Stem-derived bromelain represents the largest market share, primarily due to the ample enzyme concentration found in pineapple stems, establishing them as the most cost-efficient extraction procedure. According to a research article published in the journal Foods in February 2024, bromelain powder that is extracted from the basal stem of pineapple exhibits the highest enzymatic activity of 717 CDU/mg casein digesting units and 2909 GDU/g gelatin digesting units. Moreover, the commercially available bromelain and bromelain-based products are majorly extracted from the stems. Moreover, the extensive availability of stems as pineapple processing by-product improves its commercial profitability. In addition, stem-extracted bromelain is preferred across key sectors, especially in food processing and pharmaceuticals, where its high purity as well as potency is requisite for versatile applications. 

Breakup by Application:

• Healthcare
• Food and Beverages
• Cosmetics
• Others
   

Food and beverages hold the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes healthcare, food and beverages, cosmetics, and others. According to the report, food and beverages accounted for the largest market share.

The food and beverages industry has emerged as the dominant application segment in the global bromelain market. This product is typically utilized in food processing, especially as a natural digestive booster and meat tenderizer, ultimately driving its demand. In addition, the enzyme is widely leveraged in dietary supplements and beverages chiefly for its health benefits. Moreover, the escalating customer preference for functional as well as natural ingredients further fortifies its applications in this industry, establishing food and beverages as a key contributor to market expansion. As per industry reports, in 2023, sales of natural food products increased by 4.8%, reaching USD 209 billion.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest bromelain market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for bromelain.

North America has established itself as the leading regional market mainly due to its increased demand in major industries like cosmetics, food, and pharmaceuticals. North America’s accelerating preference for enzyme-based and natural products, combined with advanced food processing and healthcare sector, is significantly fueling the product consumption. Moreover, continuous research and regulatory certifications for bromelain’s therapeutic profile further bolster its market reach. In addition, the magnified inclination towards clean-label food products and natural ingredient-based supplements improves bromelain’s applications. Furthermore, the rising prevalence of joint diseases, like arthritis, in the region is also spurring the demand for bromelain as it is found effective in treating various cardiovascular as well as joint disorders. According to industry reports, it is anticipated that by the year 2040, 78 million adults in the United States will be living with arthritis.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the bromelain industry include Advanced Enzyme Technologies Limited, Bio-gen Extracts Private Limited., Changsha Natureway Co. Ltd., Creative Enzymes, Enzybel International (Floridienne S.A.), Enzyme Development Corporation, Enzyme Technologies (PTY) Ltd., Guangxi Nanning Javely Biological Products Co. Ltd., Hong Mao Biochemicals Co. Ltd., Mitushi Biopharma, and Xena Bio Herbals Pvt. Ltd.
  
  (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
   
• The competitive landscape of the market is represented by the presence of various major companies, including specialized enzyme producers and large multinational firms. Such companies are currently focusing on strategic acquisitions, product portfolio expansion, and product innovation to fortifying their leadership in the market. For instance, in January 2023, Sun Pharma, one of the major pharmaceutical companies, announced the acquisition of anti-inflammatory brands Phlogam, Disperzyme, and Disperzyme-CD from Aksigen Hospital Care to strengthen its anti-inflammatory drugs portfolio. These are regulatory approved brands that consists of proteolytic enzymes, like bromelain, and are prescribed for the treatment of post-operative inflammation. Moreover, competition is also amplified in terms of supply chain efficiency, product quality, and pricing. In addition, heavy investments in research and development for new enzyme applications, especially in cosmetics and pharmaceuticals, is further magnifying competition among market players.

Bromelain Market News:

• In April 2024, AstroZhi, an Irish healthcare company, launched VitaZhi, a dietary supplement range, that is formulated to mitigate the effects of SARS-CoV-2 virus and is incorporated with effective ingredients, including bromelain.
• In February 2024, Bharat Serum and Vaccines, a major biopharmaceutical firm in India, announced a distribution partnership with MediWound to supply NexoBrid, a burn cream enriched with the proteolytic enzyme bromelain, in the Indian market.

Bromelain Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the bromelain market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global bromelain market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the bromelain industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.